We just received data on a new analyst forecast for $MRNA. Jessica Fye from JP Morgan set a price target of 102.0 for MRNA.
To track analyst ratings and price targets for $MRNA, check out Quiver Quantitative's $MRNA forecast page.
Should you buy $MRNA?
Some analysts are better than others. To view the past performance of JP Morgan, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$MRNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 13 analysts offer price targets for $MRNA in the last 6 months, with a median target of $102.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $200.0 on 11/17/2026
- Jessica Fye from JP Morgan set a target price of $102.0 on 11/17/2026
- Salveen Richter from Goldman Sachs set a target price of $195.0 on 11/09/2026
- Edward Tenthoff from Piper Sandler set a target price of $305.0 on 11/09/2026
- Tyler Van Buren from TD Cowen set a target price of $90.0 on 10/21/2026
- Geoff Meacham from Citigroup set a target price of $80.0 on 09/30/2026
- Simon Baker from Rothschild & Co set a target price of $81.0 on 09/03/2026
$MRNA Insider Trading Activity
$MRNA insiders have traded $MRNA stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- STEPHEN HOGE (President) has made 0 purchases and 7 sales selling 265,616 shares for an estimated $35,050,341.
- STEPHANE BANCEL (Chief Executive Officer) has made 0 purchases and 4 sales selling 499,246 shares for an estimated $28,715,011.
- JAMES M MOCK (Chief Financial Officer) has made 0 purchases and 2 sales selling 34,836 shares for an estimated $4,685,093.
- SHANNON THYME KLINGER (Chief Legal Officer) has made 0 purchases and 2 sales selling 6,942 shares for an estimated $659,316.
- NOUBAR AFEYAN sold 9,263 shares for an estimated $433,878
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MRNA Congressional Stock Trading
Members of Congress have traded $MRNA stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/20.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 3 times. They made 1 purchase worth up to $15,000 on 08/19 and 2 sales worth up to $30,000 on 09/24, 08/19.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$MRNA Hedge Fund Activity
We have seen 649 institutional investors add shares of $MRNA stock to their portfolio, and 402 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 27,296,982 shares (-98.6%) from their portfolio in Q3 2026, for an estimated $5,256,579,823
- FMR LLC added 7,096,057 shares (+13.7%) to their portfolio in Q3 2026, for an estimated $1,366,487,696
- BAILLIE GIFFORD & CO removed 6,768,791 shares (-37.2%) from their portfolio in Q3 2026, for an estimated $1,303,466,082
- TWO SIGMA INVESTMENTS, LP removed 6,723,992 shares (-93.5%) from their portfolio in Q3 2026, for an estimated $1,294,839,139
- D. E. SHAW & CO., INC. removed 5,157,808 shares (-99.5%) from their portfolio in Q2 2026, for an estimated $361,201,294
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 4,838,884 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $931,823,891
- MORGAN STANLEY removed 3,522,568 shares (-36.9%) from their portfolio in Q3 2026, for an estimated $678,340,919
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.